Associated Retinal Consultants

Royal Oak, Michigan 48073

0 studies enrolling now · 10 studies all time

What they study most

Age-Related Macular Degeneration, Geographic Atrophy of the Macula, Macular Degeneration, Neovascular Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Proliferative Vitreoretinopathy, Retinal Vein Occlusion, Vitreomacular Adhesion Including Macular Hole, Wet Macular Degeneration

Studies at this site

• Extension Study for the Port Delivery System With Ranibizumab (Portal) — Recruiting now
• Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration — Running, not enrolling
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy — Completed
• Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration — Completed
• Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept — Completed
• A Long-Term Monitoring Study of the IMT-002 Patients — Completed
• Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole — Completed
• Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) — Completed
• Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD) — Completed